<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang Y</submitter><funding>Shenyang Science and Technology Bureau (Science and Technology Bureau of Shenyang)</funding><funding>National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund</funding><funding>National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund)</funding><funding>National Natural Science Foundation of China</funding><funding>Shenyang Science and Technology Bureau</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>167</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8983679</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(1)</volume><pubmed_abstract>Pathological cardiac hypertrophy is a key contributor in heart failure (HF). Long non-coding RNAs (lncRNAs) and N&lt;sup>6&lt;/sup>-methyladenosine (m&lt;sup>6&lt;/sup>A) modification play a vital role in cardiac hypertrophy respectively. Nevertheless, the interaction between lncRNA and m&lt;sup>6&lt;/sup>A methylase in cardiac hypertrophy is scarcely reported. Here, we constructed a cardiac hypertrophy mouse model by transverse aortic constriction (TAC) surgery and H9c2 cell model by stimulating with AngII. We found that lncRNA MIAT mRNA level, and m&lt;sup>6&lt;/sup>A RNA methylation reading protein Ythdf2 mRNA and protein levels, were significantly increased in the cardiac hypertrophy model both in vivo and vitro. MIAT or Ythdf2 overexpression aggravated cardiac hypertrophy, and vice versa. Through bioinformat</pubmed_abstract><journal>Cell death discovery</journal><pubmed_title>The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m&lt;sup>6&lt;/sup>A RNA methylation reading protein Ythdf2.</pubmed_title><pmcid>PMC8983679</pmcid><funding_grant_id>19-112-4-003</funding_grant_id><funding_grant_id>8197021725</funding_grant_id><pubmed_authors>Mbikyo MB</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Zhang N</pubmed_authors></additional><is_claimable>false</is_claimable><name>The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m&lt;sup>6&lt;/sup>A RNA methylation reading protein Ythdf2.</name><description>Pathological cardiac hypertrophy is a key contributor in heart failure (HF). Long non-coding RNAs (lncRNAs) and N&lt;sup>6&lt;/sup>-methyladenosine (m&lt;sup>6&lt;/sup>A) modification play a vital role in cardiac hypertrophy respectively. Nevertheless, the interaction between lncRNA and m&lt;sup>6&lt;/sup>A methylase in cardiac hypertrophy is scarcely reported. Here, we constructed a cardiac hypertrophy mouse model by transverse aortic constriction (TAC) surgery and H9c2 cell model by stimulating with AngII. We found that lncRNA MIAT mRNA level, and m&lt;sup>6&lt;/sup>A RNA methylation reading protein Ythdf2 mRNA and protein levels, were significantly increased in the cardiac hypertrophy model both in vivo and vitro. MIAT or Ythdf2 overexpression aggravated cardiac hypertrophy, and vice versa. Through bioinformat</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-21T16:51:51.962Z</modification><creation>2025-04-21T16:51:51.962Z</creation></dates><accession>S-EPMC8983679</accession><cross_references><pubmed>35383152</pubmed><doi>10.1038/s41420-022-00977-8</doi></cross_references></HashMap>